CClinicalTrials.gg
CompletedNCT05188625iSelf-LearnUpdated Jan 12, 2022

Online Self-learning for Women With Gestational Diabetes Mellitus

An interventional study of Telesupport - Telehealth in Gestational Diabetes, sponsored by KK Women's and Children's Hospital. Completed at 1 site in Singapore. Open to female participants aged 21 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-01-12.

Sponsored by KK Women's and Children's Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Jan 2021, registered Nov 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
21 Years and older
Sex
Female
01

Study summary

This study aims to determine the feasibility and acceptability of using telehealth in the care of women with Gestational Diabetes Mellitus (GDM) by providing a self-learning alternative via an online portal compared to a one-to-one dietary education, conducted face-to-face in a dietitian clinic. The investigators hypothesize that the use of technology would enable a higher percentage of women to receive the necessary dietary education, thereby empowering behaviour change and resulting in positive maternal blood glucose control and pregnancy outcomes.

The primary hypothesis is that the new care model will reach out to a higher proportion compared to the conventional model (Service utilization), as determined by the completion of the online self-learning, comparing it to attendance rates with the conventional model.

The secondary hypothesis is that the new care model will be able to provide care that would be comparable to those in the traditional outpatient clinic setting, as measured by the blood glucose and pregnancy outcomes, as well as patient satisfaction and patient experience.

Read the detailed description

GDM is a significant health issue amongst women. Medical nutrition therapy is established as the first-line treatment for GDM. The goal is to support maternal and foetal nutrition in order to ensure adequate pregnancy weight gain and foetal growth, whilst at the same time, maintain optimal glycemic control. Health education continues to play an important role in managing GDM. However, not all women with GDM receive dietary education as recommended, due to a multitude of personal and circumstantial factors. Failure to attend diabetes-related appointment has been associated with poorer glycaemic control by 36 weeks' gestation, which leads to a higher risk of macrosomia and an unfavourable set-up for neonatal outcomes. Therefore, this pilot study aims to determine the feasibility and acceptability of using telehealth in the dietary management of GDM compared with the current standard care, i.e. traditional face-to-face dietary education.

A total of 50 women diagnosed with GDM will be randomized to the standard care or telehealth, where self-education will be done via an online portal and subsequently followed up by teleconsult. Both groups will be followed up by the dietitian every 2-4 weeks until delivery either face-to-face (control group) or telehealth video consultation (intervention group). Each participant will be provided with a set of glucometer and the required consumables for home blood glucose monitoring.

Outcomes to determine the success of the study will be the percentage of women who completed dietary education. Other outcomes will include birth outcome data - birth weight to assess for large-for-gestational age baby, type of delivery, incidence of neonatal hypoglycaemia and total maternal weight gain, to establish the efficacy of this model of care. The effectiveness of self-learning will be assessed using pre- and post-test assessment quizzes. The experience and satisfaction of this model will also be surveyed.

02

Conditions studied

  • Gestational Diabetes

Browse trials for

Keywords

  • Gestational Diabetes Mellitus
  • GDM
  • Medical Nutrition Therapy
  • Telehealth
03

In context

Diabetes, Gestational

842 studies on the registry are indexed under Diabetes, Gestational; 198 are open to participants now.

This study's enrollment of 50 is below the median of 110 across 550 interventional studies indexed under Diabetes, Gestational.

Browse Diabetes, Gestational studies →

Lead sponsor

KK Women's and Children's Hospital is the lead sponsor of 136 studies on the registry; 33 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Singleton pregnancy
  • Women diagnosed with GDM before 32 weeks
  • Women willing and have provided written consent to participate
  • Women with ability to use telemedicine services after briefed
  • Women who have sufficient communication abilities (written, listening and spoken) to be fully involved
  • Women who have access to phone and internet
  • Women willing to download and send blood glucose readings to research team.

Exclusion criteria

Exclusion Criteria:

  • Multiple pregnancies
  • Gestational age 35 weeks and above
  • Women with existing Type 1 or Type 2 Diabetes
  • Women receiving oral steroid therapy
  • Women with evidence of fetal complications (such as fetal anomalies, intrauterine growth retardation) and known history of pregnancy complications (e.g. pre-eclampsia)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
50 participants (actual)

Study arms

  • No intervention
    Control arm

    This group will receive the standard care of face-to-face dietitian counselling sessions.

  • Experimental
    Intervention arm

    This group will receive online self-paced dietary education, and followed up by telehealth video consultation with dietitian for dietary counselling.

    Other: Telesupport - Telehealth

Interventions

  • OtherTelesupport - Telehealth

    Online self-paced dietary education videos; Dietary counselling via video consultation; Blood glucose monitoring via a specially-designed health app

06

What researchers measure

Primary outcomes

  1. Completion rate

    The completion of online dietary education

    Time frame: Completion of online dietary education at Day 3

  2. Attendance rate

    The attendance of each dietitian visit

    Time frame: Mean attendance of each dietitian visit throughout study completion for an average of up to 12 weeks.

Secondary outcomes

  1. Knowledge assessment using a quiz

    The change in knowledge assessment, assessed as difference in score of quiz before and after dietary education

    Time frame: At baseline Day 0 and between Day 3 (for intervention group) and Day 14 (for control group)

  2. Patient experience

    The Hospital Consumer Assessment of Healthcare Providers and Systems Survey (HCAHPS) is used to collect information on how satisfied patients are with their healthcare providers; includes questions on level of care \& concern, treated with kindness \& compassion, courtesy \& respect, being listened to

    Time frame: At end of study up to 12 weeks

  3. Telehealth usability

    Usefulness, ease of use, reliability, interface and interaction quality of the telesupport-telehealth service using a specific questionnaire (International Journal of Telerehabilitation 2016; 8(1): 3-10)

    Time frame: At end of study up to 12 weeks

  4. Glycaemic control

    Blood glucose profile ranges pre- and post-meals

    Time frame: Every 2-4 weeks throughout the study, up to 12 weeks

  5. Maternal outcome

    Total gestational weight gain in kilograms

    Time frame: At end of study, up to 12 weeks

  6. Foetal outcome 1

    Birth weight in grams

    Time frame: At end of study, up to 12 weeks

  7. Foetal outcome 2

    Neonatal hypoglycaemia as defined by blood glucose level below 3.0mmol/L

    Time frame: At end of study, up to 12 weeks

07

Study locations

1 site
  • KK Women's and Children's Hospital
    Singapore, 229899, Singapore
08

References and documents

Study documents

  • Study protocol · Feb 10, 2021
  • Informed consent form · Feb 10, 2021

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 12, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05188625
Lead sponsor
KK Women's and Children's Hospital
Responsible party
Han Wee Meng (Senior Principal Dietitian, Head of Nutrition & Dietetics Department, Principal Investigator, KK Women's and Children's Hospital) — Principal investigator
First posted
Jan 12, 2022
Start date
Jan 13, 2021
Primary completion
Jun 23, 2021
Completion
Aug 13, 2021
Last update
Jan 12, 2022

Study contacts

Wee Meng Han, PhD
principal investigator · KK Women's and Children's Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion